Condition
High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements clinical trials and research
As of November 12, 2026, Find a Trial lists 4 High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements clinical trials that are recruiting, at sites in 3 countries (most in United States (2), Australia (1), Italy (1)). By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| How MYC gene changes relate to the tumor immune environment in diffuse large B‑cell and high‑grade B‑cell lymphoma | — | Alessandria and 19 other locations | Recruiting | Sep 19, 2024 |
| Combination therapy with Epcoritamab for relapsed aggressive B-cell lymphoma | Phase 2 | Melbourne, Victoria | Recruiting | Mar 1, 2024 |
| Using ascorbic acid with chemotherapy to treat relapsed or refractory lymphoma and related conditions | Phase 2 | Mankato, Minnesota and 3 other locations | Recruiting | Feb 1, 2018 |
| Personalized NK cell therapy after umbilical cord blood transplant for leukemia | Phase 2 | Houston, Texas | Recruiting | Apr 5, 2016 |
All recruiting trials (4)
-
How MYC gene changes relate to the tumor immune environment in diffuse large B‑cell and high‑grade B‑cell lymphoma
This project will see if MYC gene changes and the tumor's immune environment are linked in adults (18–79) who received curative treatment for diffuse large B‑cell or high‑grade B‑cell lymphoma.
-
Combination therapy with Epcoritamab for relapsed aggressive B-cell lymphoma
This study is testing if adding Epcoritamab to chemotherapy helps people with relapsed aggressive B-cell lymphoma get better before a stem cell transplant and live longer without the disease coming back.
-
Using ascorbic acid with chemotherapy to treat relapsed or refractory lymphoma and related conditions
This study is testing if adding vitamin C to standard chemotherapy can help people with relapsed or hard-to-treat lymphomas and related blood conditions feel better.
-
Personalized NK cell therapy after umbilical cord blood transplant for leukemia
This study is testing if a special treatment using personalized immune cells from umbilical cord blood can help people with leukemia feel better after their transplant.
Related topics
Quick answers
How many High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), Australia (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.